Announcing your GivingTuesday winner: Dr Philipp Lange

“Side-effects from cancer treatments are particularly daunting for children, who will live for decades after successful treatment. Thanks to the support of Canadian Cancer Society donors we can now explore new treatment options that will hopefully spare vulnerable kids from long-term damage and improve their quality of life.”
— Dr Philipp Lange

GivingTuesday is an international movement that marks the start of the giving season and rallies people to support their favourite causes and think about others.

In 2016, we added a new twist to our annual campaign. From November 22 to 29, those who made a donation in support of GivingTuesday were able to vote for one of three cancer research projects. The project that received the most votes was awarded our Great Canadian Innovation Grant. This grant supports a high-risk, high-reward cancer research project that offers the potential to dramatically advance our progress against cancer.

Dr Philipp Lange was awarded our third annual Great Canadian Innovation Grant. Through his project, Dr Lange is seeking to reduce long-term health issues in childhood cancer survivors by exploring unique proteins in leukemia to find more effective and less harmful treatments for children.

“Side-effects from cancer treatments are particularly daunting for children, who will live for decades after successful treatment,” says Dr Lange. “Thanks to the support of Canadian Cancer Society donors we can now explore new treatment options that will hopefully spare vulnerable kids from long-term damage and improve their quality of life.”

Dr Lange is an Assistant Professor of Pathology at University of British Columbia, an investigator with the Michael Cuccione Childhood Cancer Research Program at BC Children's Hospital and a Canada Research Chair in Translational Proteomics of Pediatric Malignancies.